PIGF and breast carcinoma: In patients with breast cancer receiving chemotherapy (e.g., doxorubicin and trastuzumab), Ky et al. found PIGF to be increased in the plasma of patients at 3 months following treatment; however, plasma PIGF was not associated with cardiotoxicity [59].